Skip to main content
Top
Published in: Pediatric Nephrology 11/2018

01-11-2018 | Original Article

Prevalence and predictors of blood transfusion after pediatric kidney transplantation

Authors: Katherine M. Richards, Rebecca A. Spicer, Elizabeth Craig, Sean E. Kennedy

Published in: Pediatric Nephrology | Issue 11/2018

Login to get access

Abstract

Background

Blood transfusion after kidney transplant carries a risk of sensitization to the graft as well as blood borne infections.
The aim of this study was to describe the prevalence of blood transfusions in pediatric recipients of kidney transplants and to determine the factors associated with transfusions during the perioperative period. Additionally, to describe the changes in hemoglobin levels during the first 12 months following transplant.

Method

A retrospective, single center analysis using data collected prospectively between 2010 and 2017. Red blood cell transfusion within the first week after transplant and anemia at 3 months were used as outcomes. Multivariate analysis was performed on significant variates with results described according to odds ratio (OR) and interquartile range (IQR).

Results

Transfusions were given after 21 of 42 (50%) transplants in recipients aged between 1 and 17 years (median 14 years). Age, height, weight, and pre-transplant hemoglobin predicted transfusion in univariate analyses. Regression analysis identified pre-transplant hemoglobin as an independent factor (OR 0.85, IQR 0.73–0.98; p = 0.02). Anemia was present at 3 months after 15 (36%) transplants. Anemia at 3 months was associated with older and larger recipients, lower pre-transplant hemoglobin, and lower estimated glomerular filtration rate (eGFR) on univariate analysis. Logistic regression analysis identified eGFR at 3 months as the only independent predictor of anemia at 3 months (OR 0.93, IQR 0.87–0.99; p = 0.04).

Conclusions

Transfusions are prevalent in the perioperative period after pediatric kidney transplantation. Lower pre-transplant hemoglobin increases the risk of transfusion. Graft function predicts hemoglobin levels at 3 months.
Literature
1.
go back to reference Kausman JY, Powell HR, Jones CL (2004) Anemia in pediatric renal transplant recipients. Pediatr Nephrol 19:526–530CrossRefPubMed Kausman JY, Powell HR, Jones CL (2004) Anemia in pediatric renal transplant recipients. Pediatr Nephrol 19:526–530CrossRefPubMed
2.
go back to reference Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra O, Alexander SR (2002) Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40:1306CrossRefPubMed Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra O, Alexander SR (2002) Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40:1306CrossRefPubMed
3.
go back to reference Galutira PJ, Del Rio M (2012) Understanding renal posttransplantation anemia in the pediatric population. Pediatr Nephrol 27:1079–1085CrossRefPubMed Galutira PJ, Del Rio M (2012) Understanding renal posttransplantation anemia in the pediatric population. Pediatr Nephrol 27:1079–1085CrossRefPubMed
4.
go back to reference Kamar N, Rostaing L, Ignace S, Villar E (2012) Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transpl 26:461–469CrossRef Kamar N, Rostaing L, Ignace S, Villar E (2012) Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis. Clin Transpl 26:461–469CrossRef
5.
go back to reference Verghese P, Gillingham K, Matas A, Chinnakotla S, Chavers B (2016) Post-transplant blood transfusions and pediatric renal allograft outcomes. Pediatr Transplant 20:939–945CrossRefPubMedPubMedCentral Verghese P, Gillingham K, Matas A, Chinnakotla S, Chavers B (2016) Post-transplant blood transfusions and pediatric renal allograft outcomes. Pediatr Transplant 20:939–945CrossRefPubMedPubMedCentral
6.
7.
go back to reference Faravardeh A, Eickhoff M, Jackson S, Issa N, Dunn T, Matas A, Ibrahim H (2013) Frequency of blood transfusion episodes after kidney transplantation is associated with development of class II donor specific antibodies. Am J Transplant 13:194 Faravardeh A, Eickhoff M, Jackson S, Issa N, Dunn T, Matas A, Ibrahim H (2013) Frequency of blood transfusion episodes after kidney transplantation is associated with development of class II donor specific antibodies. Am J Transplant 13:194
8.
go back to reference Ferrandiz I, Congy-Jolivet N, Del Bello A, Debiol B, Trébern-Launay K, Esposito L, Milongo D, Dörr G, Rostaing L, Kamar N (2016) Impact of early blood transfusion after kidney transplantation on the incidence of donor-specific anti-HLA antibodies. Am J Transplant 16:2661–2669CrossRefPubMed Ferrandiz I, Congy-Jolivet N, Del Bello A, Debiol B, Trébern-Launay K, Esposito L, Milongo D, Dörr G, Rostaing L, Kamar N (2016) Impact of early blood transfusion after kidney transplantation on the incidence of donor-specific anti-HLA antibodies. Am J Transplant 16:2661–2669CrossRefPubMed
9.
go back to reference Klein HG, Spahn DR, Carson JL (2007) Red blood cell transfusion in clinical practice. Lancet 370:415–426CrossRefPubMed Klein HG, Spahn DR, Carson JL (2007) Red blood cell transfusion in clinical practice. Lancet 370:415–426CrossRefPubMed
10.
go back to reference Kidney disease: Improving global outcomes (KDIGO) anemia work group (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl:279–335 Kidney disease: Improving global outcomes (KDIGO) anemia work group (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl:279–335
11.
go back to reference Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF (2010) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 153:23–33CrossRefPubMed Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF (2010) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 153:23–33CrossRefPubMed
12.
go back to reference Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D (2005) Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16:2180–2189CrossRefPubMed Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D (2005) Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16:2180–2189CrossRefPubMed
13.
go back to reference Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019–2032CrossRefPubMed Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019–2032CrossRefPubMed
14.
go back to reference Abbott EM, Nandyala SV, Schwend RM (2014) Does a kaolin-impregnated hemostatic dressing reduce intraoperative blood loss and blood transfusions in pediatric spinal deformity surgery? Spine 39:E1174–E1180CrossRefPubMed Abbott EM, Nandyala SV, Schwend RM (2014) Does a kaolin-impregnated hemostatic dressing reduce intraoperative blood loss and blood transfusions in pediatric spinal deformity surgery? Spine 39:E1174–E1180CrossRefPubMed
15.
go back to reference Fearon JA (2004) Reducing allogenic blood transfusions during pediatric cranial vault surgical procedures: a prospective analysis of blood recycling. Plast Reconstr Surg 113:1126–1130CrossRefPubMed Fearon JA (2004) Reducing allogenic blood transfusions during pediatric cranial vault surgical procedures: a prospective analysis of blood recycling. Plast Reconstr Surg 113:1126–1130CrossRefPubMed
16.
go back to reference Fearon JA, Weinthal J (2002) The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg 109:2190–2196CrossRefPubMed Fearon JA, Weinthal J (2002) The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg 109:2190–2196CrossRefPubMed
17.
go back to reference Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843CrossRefPubMed Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843CrossRefPubMed
18.
go back to reference Cameron BM, Kennedy SE, Rawlinson WD, Mackie FE (2017) The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children. Pediatr Transplant 21(1)CrossRef Cameron BM, Kennedy SE, Rawlinson WD, Mackie FE (2017) The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children. Pediatr Transplant 21(1)CrossRef
19.
go back to reference (2016) Patient blood management guidelines: Module 6 – Neonatal and Paediatrics. In: Authority NB (ed). National Blood Authority, Australia, Canberra, Australia (2016) Patient blood management guidelines: Module 6 – Neonatal and Paediatrics. In: Authority NB (ed). National Blood Authority, Australia, Canberra, Australia
20.
go back to reference Scornik JC, Schold JD, Bucci M, Meier-Kriesche H-U (2009) Effects of blood transfusions given after renal transplantation. Transplantation 87:1381–1386CrossRefPubMed Scornik JC, Schold JD, Bucci M, Meier-Kriesche H-U (2009) Effects of blood transfusions given after renal transplantation. Transplantation 87:1381–1386CrossRefPubMed
21.
go back to reference Hoad VC, Gibbs T, Ravikumara M, Nash M, Levy A, Tracy SL, Mews C, Perkowska-Guse Z, Faddy HM, Bowden S (2017) First confirmed case of transfusion-transmitted hepatitis E in Australia. Med J Aust 206:289–290CrossRefPubMed Hoad VC, Gibbs T, Ravikumara M, Nash M, Levy A, Tracy SL, Mews C, Perkowska-Guse Z, Faddy HM, Bowden S (2017) First confirmed case of transfusion-transmitted hepatitis E in Australia. Med J Aust 206:289–290CrossRefPubMed
22.
go back to reference Rheault MN, Molony JT, Nevins T, Herzog CA, Chavers BM (2017) Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis. Kidney Int 91:177–182CrossRefPubMed Rheault MN, Molony JT, Nevins T, Herzog CA, Chavers BM (2017) Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis. Kidney Int 91:177–182CrossRefPubMed
23.
go back to reference Krischock LA, van Stralen KJ, Verrina E, Tizard EJ, Bonthuis M, Reusz G, Hussain FK, Jankauskiene A, Novljan G, Spasojevic-Dimitrijeva B, Podracka L, Zaller V, Jager KJ, Schaefer F, Registry EE-E (2016) Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA registry. Pediatr Nephrol 31:325–333CrossRefPubMed Krischock LA, van Stralen KJ, Verrina E, Tizard EJ, Bonthuis M, Reusz G, Hussain FK, Jankauskiene A, Novljan G, Spasojevic-Dimitrijeva B, Podracka L, Zaller V, Jager KJ, Schaefer F, Registry EE-E (2016) Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA registry. Pediatr Nephrol 31:325–333CrossRefPubMed
Metadata
Title
Prevalence and predictors of blood transfusion after pediatric kidney transplantation
Authors
Katherine M. Richards
Rebecca A. Spicer
Elizabeth Craig
Sean E. Kennedy
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 11/2018
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-018-4017-0

Other articles of this Issue 11/2018

Pediatric Nephrology 11/2018 Go to the issue